Trial
NCT01212588
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
—
Condition
Borderline Personality Disorder
Intervention
mifepristone
Why stopped
Funding ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-26